Fam83a Inhibitors
Chemical inhibitors of FAM83A play a significant role in modulating its function by targeting various signaling pathways with which this protein is associated. Staurosporine, a well-known kinase inhibitor, can suppress the activity of protein kinases that are vital for the signaling pathways involving FAM83A. This results in a broad inhibition of the activation and function of FAM83A. Similarly, U0126 and PD98059 target MEK1/2 and MEK respectively, both of which are upstream regulators of the MAPK/ERK pathway. Inhibition of these kinases by U0126 and PD98059 can lead to a disruption of the MAPK/ERK pathway and consequently inhibit the function of FAM83A. LY294002 and Wortmannin, both inhibitors of PI3K, can downregulate PI3K-AKT signaling, which is crucial for FAM83A's role in cellular processes. This downregulation can subsequently reduce the activity of FAM83A within these pathways.
Moreover, Rapamycin forms a complex with FKBP12 that can inhibit mTOR, a component of the cellular machinery where FAM83A is implicated, resulting in the attenuation of FAM83A's role in cell survival and proliferation. SP600125, by selectively inhibiting JNK, and SB203580, by targeting p38 MAP kinase, can impede stress signaling pathways and regulate cell cycle processes that involve FAM83A, leading to a decrease in its functional activity. PP2 and Dasatinib both serve as inhibitors for Src family kinases, with Dasatinib also inhibiting Bcr-Abl. The inhibition of these kinases can disrupt the signaling pathways that FAM83A is a part of, thereby reducing its functionality. Lastly, Y-27632 and Gefitinib target Rho-associated protein kinase (ROCK) and EGFR respectively. Inhibition by Y-27632 can affect cell shape and motility, whereas Gefitinib can decrease EGFR signaling, both pathways being important for the proper functioning of FAM83A. Through these mechanisms, these inhibitors can effectively reduce the activity of FAM83A.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine inhibits protein kinases which are crucial for various signaling pathways that family with sequence similarity 83 member A (FAM83A) is involved in, thereby inhibiting the activation and function of FAM83A. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 inhibits MEK1/2, which are upstream of the MAPK/ERK pathway; FAM83A has been implicated in modulating this pathway, thus inhibition of MEK1/2 inhibits the pathway activity, affecting FAM83A function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, and by inhibiting PI3K, it affects downstream signaling including AKT which is related to FAM83A signaling, leading to inhibition of FAM83A's associated cellular processes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin binds to FKBP12 and the complex inhibits mTOR, a key part of the pathway involved in cell survival and proliferation where FAM83A plays a role, resulting in an inhibition of FAM83A-related functions. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 selectively inhibits c-Jun N-terminal kinase (JNK), which is involved in stress signaling pathways that can intersect with FAM83A signaling, leading to inhibition of FAM83A's role within the cell. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a selective inhibitor of p38 MAP kinase, which is involved in the regulation of cell cycle and stress response where FAM83A is known to have a role, thus its inhibition can reduce the functional activity of FAM83A. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 selectively inhibits MEK, which works upstream of ERK in the MAPK pathway; inhibiting this kinase disrupts the signaling cascade that FAM83A may influence, leading to its functional inhibition. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is an inhibitor of PI3K which can lead to a decrease in AKT signaling; since AKT is part of cell proliferation and survival pathways where FAM83A is implicated, this results in FAM83A inhibition. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is a Src family kinase inhibitor, and by inhibiting Src kinases, it disrupts downstream signaling that includes pathways where FAM83A is a component, thus inhibiting FAM83A's functions. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib inhibits Src family kinases as well as Bcr-Abl, both of which are involved in signaling pathways that intersect with the biological processes that FAM83A influences, thereby inhibiting FAM83A function. | ||||||